Immutep Says Root Cause Analysis Identified N-Glycan Structural Differences Between 200 L And 2,000 L Efti Batches Used In Discontinued TACTI-004; Contracts New 200 L Run, Targets Next Trial Start In 2H CY2027

Loading news article.

Immutep Says Root Cause Analysis Identified N-Glycan Structural Differences Between 200 L And 2,000 L Efti Batches Used In Discontinued TACTI-004; Contracts New 200 L Run, Targets Next Trial Start In 2H CY2027 | WAPE

Immutep Says Root Cause Analysis Identified N-Glycan Structural Differences Between 200 L And 2,000 L Efti Batches Used In Discontinued TACTI-004; Contracts New 200 L Run, Targets Next Trial Start In 2H CY2027

Article summary

Related companies

Analyzed by WAPE AI.

Comments —